No Data
No Data
Jasper Launches AI Studio, Empowering Enterprise Marketing Teams to Build & Scale Generative AI Solutions
Insider Sale: Chief Operating Officer of $JSPR (JSPR) Sells 900 Shares
BMO Capital Initiates Coverage On Jasper Therapeutics With Outperform Rating, Announces Price Target of $63
Jasper Therapeutics Analyst Ratings
BMO Capital Initiates Jasper Therapeutics(JSPR.US) With Buy Rating, Announces Target Price $63
Express News | Jasper Therapeutics Inc - Initial Data Expected in Second Half of 2025